$ARNI Arno Therapeutics, Inc Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Arno Therapeutics, Inc.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Arno Therapeutics, Inc. Insider overview, share value development, latest insider transactions and email notifications about new events in Arno Therapeutics, Inc for free.

CIK Number: 0001195116
IRS Number: 522286452
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: ARNI
Company Address: 200 ROUTE 31 NORTH SUITE 104 FLEMINGTON 08822
Phone number: 862-703-7170
Former name: LAURIER INTERNATIONAL INC, date of change: 2002-10-01
Former name: LAURIER INTERNATIONAL INC, date of change: 2002-10-01

Arno Therapeutics, Inc. operates as a biopharmaceutical company, which focuses on the clinical development of targeted cancer therapies and novel drug candidates for unmet medical needs. It develops pre-clinical and clinical-stage product under the following brands: Onapristone, AR-42, and AR-12. The company was founded by Peter Morgan Kash, David M. Tanen, and Joshua A. Kazam in March 2000 and is headquartered in Flemington, NJ.

Market Capitalization: $4.19M
Prev close: $0.08
Average Daily Volume: 40,903
Days Low: $0.08
Year Low: $0.06
Year High: $0.92

Arno Therapeutics, Inc Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jan 03 2017ARNIArno Therapeutics, ...SUSSMAN S DONALDOption ExerciseS1.751,383,7022,421,4790
Jan 03 2017ARNIArno Therapeutics, ...SUSSMAN S DONALDOption ExerciseS1.141,605,8091,830,6220
Jan 03 2017ARNIArno Therapeutics, ...SUSSMAN S DONALDSellS0.004,285,1110714,2855 M to 714.3 K (-85.71 %)
Oct 05 2016ARNIArno Therapeutics, ...TANEN DAVID MSecretaryOption ExerciseP0.4471,42831,25071,428
Oct 05 2016ARNIArno Therapeutics, ...TANEN DAVID MSecretaryBuyP0.00142,8570314,569171.7 K to 314.6 K (+83.20 %)
Sep 08 2016ARNIArno Therapeutics, ...SUSSMAN S DONALD10% OwnerOption ExerciseP0.44357,142156,250357,142
Sep 08 2016ARNIArno Therapeutics, ...SUSSMAN S DONALD10% OwnerBuyP0.00714,2850714,2850 to 714.3 K
Aug 17 2016ARNIArno Therapeutics, ...Belldegrun ArieDirectorOption ExerciseP0.44357,142156,250357,142
Aug 17 2016ARNIArno Therapeutics, ...Belldegrun ArieDirectorBuyP0.00714,28502,262,8381.5 M to 2.3 M (+46.13 %)
Aug 17 2016ARNIArno Therapeutics, ...Kariv TomerDirectorOption ExerciseP0.4451,05022,33451,050
Aug 17 2016ARNIArno Therapeutics, ...Kariv TomerDirectorOption ExerciseP0.44131,50857,535131,508
Aug 17 2016ARNIArno Therapeutics, ...Kariv TomerDirectorOption ExerciseP0.44174,58476,381174,584
Aug 17 2016ARNIArno Therapeutics, ...Kariv TomerDirectorBuyP0.00102,1000496,068394 K to 496.1 K (+25.92 %)
Aug 17 2016ARNIArno Therapeutics, ...Kariv TomerDirectorBuyP0.00263,01701,277,9051 M to 1.3 M (+25.92 %)
Aug 17 2016ARNIArno Therapeutics, ...Kariv TomerDirectorBuyP0.00349,16801,696,4951.3 M to 1.7 M (+25.92 %)

View all Arno Therapeutics, Inc insider transactions.